Trials / Completed
CompletedNCT03274167
Efficacy of Gabapentin in Alcohol Dependency Treatment
Efficacy of Gabapentin in Alcohol Dependency Treatment: a Double-blinded Randomized Placebo-controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to study the effect of gabapentin on the number of alcohol drinking days and heavy drinking days in the Thai clinical alcohol-dependent population by using the double-blinded randomized controlled approach. One-hundred and twelve individuals with alcohol dependence were randomly assigned equally into two groups including treatment with gabapentin and placebo. Thirty-four patients (30.3%) completed the study protocol, i.e. treatment with gabapentin at least 300 mg per day or placebo orally once a day for twelve weeks. Pattern of alcohol drinking were obtained from the timelime followback. Drinking behaviors were compared between the two groups by poisson repeated measures model.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gabapentin 300mg | |
| DRUG | Placebo oral capsule |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2017-09-06
- Last updated
- 2017-09-06
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03274167. Inclusion in this directory is not an endorsement.